RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC). (Q53164620)
Jump to navigation
Jump to search
scientific article published in February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC). |
scientific article published in February 2011 |
Statements
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) (English)
C Romei
B Cosci
G Renzini
V Bottici
E Molinaro
L Agate
P Passannanti
A Biagini
C Ugolini
G Materazzi
A Pinchera
1 February 2011